Small-diameter vascular tissue engineering

Nature Reviews Cardiology

Volumn 10, Issue 7, 2013, Pages 410-421

  Seifu, Dawit G ^a   Purnama, Agung ^a   Mequanint, Kibret ^b   Mantovani, Diego ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; BLOOD VESSEL DIAMETER; BLOOD VESSEL OCCLUSION; CORONARY ARTERY ANOMALY; CORONARY ARTERY BYPASS GRAFT; GOLD STANDARD; HUMAN; INTERNAL MAMMARY ARTERY; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESPIRATORY TRACT MALFORMATION; REVIEW; SAPHENOUS VEIN GRAFT; TISSUE ENGINEERING; VASCULAR PATENCY; VASCULAR SURGERY; VASCULAR TISSUE;

ANIMALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; BLOOD VESSELS; HUMANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84881091001     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.77     Document Type: Review

References (146)

1. WHO. Cardiovascular diseases (CVDs) [online], http://www.who.int/ mediacentre/factsheets/fs317/en/index.html (2013).
2. Population Reference Bureau. World population data sheet 2012 [online], http://www.prb.org/Publications/Datasheets/2012/worldpopulationdata-sheet.aspx (2012).
3. Eisenberg, M. J. et al. Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada. Arch. Intern. Med. 165, 1506-1513 (2005).
4. Matsuo, Y. et al. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis 223, 365-371 (2012).
5. Krueger, K. D., Mitra, A. K., Del Core, M. G., Hunter, W. J. 3rd & Agrawal, D. K. A comparison of stent-induced stenosis in coronary and peripheral arteries. J. Clin. Pathol. 59, 575-579 (2006).
6. Schwann, T. A., Engoren, M., Bonnell, M., Clancy, C. & Habib, R. H. Comparison of late coronary artery bypass graft survival effects of radial artery versus saphenous vein grafting in male and female patients. Ann. Thorac. Surg. 94, 1485-1491 (2012).
7. Kannan, R. Y., Salacinski, H. J., Butler, P. E., Hamilton, G. & Seifalian, A. M. Current status of prosthetic bypass grafts: A review. J. Biomed. Mater. Res. B Appl. Biomater. 74, 570-581 (2005).
8. McBane, J. E. et al. Tissue engineering a small diameter vessel substitute: Engineering constructs with select biomaterials and cells. Curr. Vasc. Pharmacol. 10, 347-360 (2012).
9. Nobel Prize. The Nobel Prize in Physiology or Medicine 1912: Alexis Carrel [online], http://www.nobelprize.org/nobel-prizes/medicine/laureates/1912/ (2013).
10. Persijn, G. Alexis Carrel. Transpl. Int. 25, 367-368 (2012).
11. Chlupác, J., Filová, E. & Bacáková, L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol. Res. 58 (Suppl. 2), S119-S139 (2009).
12. Menzoian, J. O., Koshar, A. L. & Rodrigues, N. Alexis Carrel, Rene Leriche, Jean Kunlin, and the history of bypass surgery. J. Vasc. Surg. 54, 571-574 (2011).
13. Testart, J. Jean Kunlin (1904-1991). Ann. Vasc. Surg. 9 (Suppl.), S1-S6 (1995).
14. Sabik, J. F. 3rd. Understanding saphenous vein graft patency. Circulation 124, 273-275 (2011).
15. Gu, C. X., Yang, J. F., Zhang, H. C., Wei, H. & Li, L. K. Off-pump coronary artery bypass grafting using a bilateral internal mammary artery Y graft. J. Geriatr. Cardiol. 9, 247-251 (2012).
16. Verma, S. et al. Should radial arteries be used routinely for coronary artery bypass grafting? Circulation 110, e40-e46 (2004).
17. Desai, N. D., Cohen, E. A., Naylor, C. D. & Fremes, S. E. for the Radial Artery Patency Study Investigators. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N. Engl. J. Med. 351, 2302-2309 (2004).
18. Lee, J. D., Srivastava, M. & Bonatti, J. History and current status of robotic totally endoscopic coronary artery bypass. Circ. J. 76, 2058-2065 (2012).
19. Levonen, A. L., Vähakangas, E., Koponen, J. K. & Ylä-Herttuala, S. Antioxidant gene therapy for cardiovascular disease: Current status and future perspectives. Circulation 117, 2142-2150 (2008).
20. Akowuah, E. F., Sheridan, P. J., Cooper, G. J. & Newman, C. Preventing saphenous vein graft failure: Does gene therapy have a role? Ann. Thorac. Surg. 76, 959-966 (2003).
21. Owens, C. D., Wake, N., Conte, M. S., Gerhard-Herman, M. & Beckman, J. A. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. J. Vasc. Surg. 50, 1063-1070 (2009).
22. Schmitto, J. D., Rajab, T. K. & Cohn, L. H. Prevalence and variability of internal mammary graft use in contemporary multivessel coronary artery bypass graft. Curr. Opin. Cardiol. 25, 609-612 (2010).
23. Weintraub, W. S., Jones, E. L., Craver, J. M. & Guyton, R. A. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am. J. Cardiol. 73, 103-112 (1994).
24. Rashid, S. T., Fuller, B., Hamilton, G. & Seifalian, A. M. Tissue engineering of a hybrid bypass graft for coronary and lower limb bypass surgery. FASEB J. 22, 2084-2089 (2008).
25. Maisel, W. H. A device for proximal anastomosis of autologous coronary vein grafts: Report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health. Circulation 112, 1516-1518 (2005).
26. Voorhees, A. B. Jr, Jaretzki, A. 3rd & Blakemore, A. H. The use of tubes constructed from vinyon "N" cloth in bridging arterial defects. Ann. Surg. 135, 332-336 (1952).
27. Abbott, W. M. et al. Evaluation and performance standards for arterial prostheses. J. Vasc. Surg. 21, 746-756 (1993).
28. Bennion, R. S. et al. Patency of autogenous saphenous vein versus polytetrafluoroethylene grafts in femoropopliteal bypass for advanced ischemia of the extremity. Surg. Gynecol. Obstet. 160, 239-242 (1985).
29. Desmet, W. et al. Isolated single coronary artery: A review of 50,000 consecutive coronary angiographies. Eur. Heart J. 13, 1637-1640 (1992).
30. Hoenig, M. R., Campbell, G. R., Rolfe, B. E. & Campbell, J. H. Tissue-engineered blood vessels: Alternative to autologous grafts? Arterioscler. Thromb. Vasc. Biol. 25, 1128-1134 (2005).
31. Baguneid, M. et al. In vivo study of a model tissue-engineered small-diameter vascular bypass graft. Biotechnol. Appl. Biochem. 58, 14-24 (2011).
32. Desai, M., Seifalian, A. M. & Hamilton, G. Role of prosthetic conduits in coronary artery bypass grafting. Eur. J. Cardiothorac. Surg. 40, 394-398 (2011).
33. Medtech Insight, LLC. European Markets for Prosthetic Vacular Grafts. Ch. 3. (Medtech Insight, LCC, 2006).
34. Zilla, P., Bezuidenhout, D. & Human, P. Prosthetic vascular grafts: Wrong models, wrong questions and no healing. Biomaterials 28, 5009-5027 (2007).
35. Annis, D. Polyether-urethane elastomers for small-diameter arterial prostheses. Life Support Syst. 5, 47-52 (1987).
36. Grasl, C., Bergmeister, H., Stoiber, M., Schima, H. & Weigel, G. Electrospun polyurethane vascular grafts: In vitro mechanical behavior and endothelial adhesion molecule expression. J. Biomed. Mater. Res. A 93, 716-723 (2010).
37. Brothers, T. E., Stanley, J. C., Burkel, W. E. & Graham, L. M. Small-caliber polyurethane and polytetrafluoroethylene grafts: A comparative study in a canine aortoiliac model. J. Biomed. Mater. Res. 24, 761-771 (1990).
38. Tiwari, A., Salacinski, H., Seifalian, A. M. & Hamilton, G. New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc. Surg. 10, 191-197 (2002).
39. Rashid, S. T. et al. Cellular engineering of conduits for coronary and lower limb bypass surgery: Role of cell attachment peptides and pre-conditioning in optimising smooth muscle cells (SMC) adherence to compliant poly(carbonate-urea)urethane (MyoLinkTM) scaffolds. Eur. J. Vasc. Endovasc. Surg. 27, 608-616 (2004).
40. Seifalian, A. M. et al. In vivo biostability of a poly(carbonate-urea) urethane graft. Biomaterials 24, 2549-2557 (2003).
41. Shin'oka, T., Imai, Y. & Ikada, Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344, 532-533 (2001).
42. L'Heureux, N. et al. Technology insight: The evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat. Clin. Pract. Cardiovasc. Med. 4, 389-395 (2007).
43. Rabkin, E. & Schoen, F. J. Cardiovascular tissue engineering. Cardiovasc. Pathol. 11, 305-317 (2002).
44. Platt, J. L. & Nagayasu, T. Current status of xenotransplantation. Clin. Exp. Pharmacol. Physiol. 26, 1026-1032 (1999).
45. Nerem, R. M. & Seliktar, D. Vascular tissue engineering. Annu. Rev. Biomed. Eng. 3, 225-243 (2001).
46. Stegemann, J. P., Kaszuba, S. N. & Rowe, S. L. Review: Advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng. 13, 2601-2613 (2007).
47. Poh, M. et al. Blood vessels engineered from human cells. Lancet 365, 2122-2124 (2005).
48. McKee, J. A. et al. Human arteries engineered in vitro. EMBO Rep. 4, 633-638 (2003).
49. Kassem, M., Abdallah, B. M., Yu, Z. T., Ditzel, N. & Burns, J. S. The use of hTERT-immortalized cells in tissue engineering. Cytotechnology 45, 39-46 (2004).
50. Wang, A. J. et al. Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells. Cells Tissues Organs 195, 5-14 (2012).
51. Sundaram, S. & Niklason, L. E. Smooth muscle and other cell sources for human blood vessel engineering. Cells Tissues Organs 195, 15-25 (2012).
52. Kane, N. M. et al. Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation). Pharmacol. Ther. 129, 29-49 (2011).
53. Liu, J. Y., Peng, H. F. & Andreadis, S. T. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc. Res. 79, 24-33 (2008).
54. Gong, Z. D. & Niklason, L. E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 22, 1635-1648 (2008).
55. Bajpai, V. K. & Andreadis, S. T. Stem cell sources for vascular tissue engineering and regeneration. Tissue Eng. Part B Rev. 18, 405-425 (2012).
56. Wagner, W. et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 33, 1402-1416 (2005).
57. Matsumura, G., Miyagawa-Tomita, S., Shin'oka, T., Ikada, Y. & Kurosawa, H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108, 1729-1734 (2003).
58. Cho, S. W. et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann. Surg. 241, 506-515 (2005).
59. L'Heureux, N. et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 12, 361-365 (2006).
60. L'Heureux, N., Paquet, S., Labbe, R., Germain, L. & Auger, F. A. A completely biological tissue-engineered human blood vessel. FASEB J. 12, 47-56 (1998).
61. Peck, M., Dusserre, N., McAllister, T. N. & L'Heureux, N. Tissue engineering by self-assembly. Materials Today 14, 218-224 (2011).
62. Marelli, B. et al. Collagen-reinforced electrospun silk fibroin tubular construct as small calibre vascular graft. Macromol. Biosci. 12, 1566-1574 (2012).
63. Yao, L., Swartz, D. D., Gugino, S. F., Russell, J. A. & Andreadis, S. T. Fibrin-based tissue-engineered blood vessels: Differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng. 11, 991-1003 (2005).
64. Peng, H. F., Liu, J. Y., Andreadis, S. T. & Swartz, D. D. Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng. Part A 17, 981-990 (2011).
65. Patterson, J. T. et al. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: From the bench to the clinic and back again. Regen. Med. 7, 409-419 (2012).
66. Heine, J. et al. Tissue engineering human small-caliber autologous vessels using a xenogenous decellularized connective tissue matrix approach: Preclinical comparative biomechanical studies. Artif. Organs 35, 930-940 (2011).
67. Quint, C., Arief, M., Muto, A., Dardik, A. & Niklason, L. E. Allogeneic human tissue-engineered blood vessel. J. Vasc. Surg. 55, 790-798 (2012).
68. Birchall, M. & Hamilton, G. Tissue-engineered vascular replacements for children. Lancet 380, 197-198 (2012).
69. Olausson, M. et al. Transplantation of an allogeneic vein bioengineered with autologous stem cells: A proofofconcept study. Lancet 380, 230-237 (2012).
70. Gwyther, T. A., Hu, J. Z., Billiar, K. L. & Rolle, M. W. Directed cellular self-assembly to fabricate cell-derived tissue rings for biomechanical analysis and tissue engineering. J. Vis. Exp. e3366 (2011).
71. Norotte, C., Marga, F. S., Niklason, L. E. & Forgacs, G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30, 5910-5917 (2009).
72. Peck, M., Gebhart, D., Dusserre, N., McAllister, T. N. & L'Heureux, N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 195, 144-158 (2012).
73. Peck, M. K. et al. New biological solutions for hemodialysis access. J. Vasc. Access 12, 185-192 (2011).
74. Song, L., Wang, L., Shah, P. K., Chaux, A. & Sharifi, B. G. Bioengineered vascular graft grown in the mouse peritoneal cavity. J. Vasc. Surg. 52, 994-1002 (2010).
75. Campbell, J. H., Efendy, J. L. & Campbell, G. R. Novel vascular graft grown within recipient's own peritoneal cavity. Circ. Res. 85, 1173-1178 (1999).
76. Patel, A., Fine, B., Sandig, M. & Mequanint, K. Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc. Res. 71, 40-49 (2006).
77. Tranquillo, R. T. The tissue-engineered small-diameter artery. Ann. N. Y. Acad. Sci. 961, 251-254 (2002).
78. Kim, B. S. & Mooney, D. J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 16, 224-230 (1998).
79. Zhang, W. J., Liu, W., Cui, L. & Cao, Y. Tissue engineering of blood vessel. J. Cell. Mol. Med. 11, 945-957 (2007).
80. Vats, A., Tolley, N. S., Polak, J. M. & Gough, J. E. Scaffolds and biomaterials for tissue engineering: A review of clinical applications. Clin. Otolaryngol. Allied Sci. 28, 165-172 (2003).
81. Berglund, J. D. & Galis, Z. S. Designer blood vessels and therapeutic revascularization. Br. J. Pharmacol. 140, 627-636 (2003).
82. Martin, I., Wendt, D. & Heberer, M. The role of bioreactors in tissue engineering. Trends Biotechnol. 22, 80-86 (2004).
83. Nilsang, S. et al. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles. Biotechnol. Prog. 24, 1122-1131 (2008).
84. Nilsang, S. et al. Monoclonal antibody production using a new supermacroporous cryogel bioreactor. Biotechnol. Prog. 23, 932-939 (2007).
85. Isenberg, B. C., Williams, C. & Tranquillo, R. T. Small-diameter artificial arteries engineered in vitro. Circ. Res. 98, 25-35 (2006).
86. Bilodeau, K. & Mantovani, D. Bioreactors for tissue engineering: Focus on mechanical constraints: A comparative review. Tissue Eng. 12, 2367-2383 (2006).
87. Riha, G. M., Lin, P. H., Lumsden, A. B., Yao, Q. & Chen, C. Roles of hemodynamic forces in vascular cell differentiation. Ann. Biomed. Eng. 33, 772-779 (2005).
88. Bilodeau, K., Couet, F., Boccafoschi, F. & Mantovani, D. Design of a perfusion bioreactor specific to the regeneration of vascular tissues under mechanical stresses. Artif. Organs 29, 906-912 (2005).
89. Lee, A. A., Graham, D. A., Dela Cruz, S., Ratcliffe, A. & Karlon, W. J. Fluid shear stress-induced alignment of cultured vascular smooth muscle cells. J. Biomech. Eng. 124, 37-43 (2002).
90. Zhao, S. et al. Synergistic effects of fluid shear stress and cyclic circumferential stretch on vascular endothelial cell morphology and cytoskeleton. Arterioscler. Thromb. Vasc. Biol. 15, 1781-1786 (1995).
91. Davies, P. F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75, 519-560 (1995).
92. Weinberg, C. B. & Bell, E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231, 397-400 (1986).
93. Niklason, L. E. et al. Functional arteries grown in vitro. Science 284, 489-493 (1999).
94. Niklason, L. E. Medical technology: Replacement arteries made to order. Science 286, 1493-1494 (1999).
95. Kolpakov, V., Rekhter, M. D., Gordon, D., Wang, W. H. & Kulik, T. J. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery: Analysis of the role of individual cell types. Circ. Res. 77, 823-831 (1995).
96. Jackson, Z. S., Gotlieb, A. I. & Langille, B. L. Wall tissue remodeling regulates longitudinal tension in arteries. Circ. Res. 90, 918-925 (2002).
97. Kanda, K. & Matsuda, T. Behavior of arterial wall cells cultured on periodically stretched substrates. Cell Transplant. 2, 475-484 (1993).
98. Hirai, J. & Matsuda, T. Self-organized, tubular hybrid vascular tissue composed of vascular cells and collagen for lowpressureloaded venous system. Cell Transplant. 4, 597-608 (1995).
99. Hirai, J. & Matsuda, T. Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen: Tissue regeneration process. Cell Transplant. 5, 93-105 (1996).
100. Bilodeau, K., Couet, F., Boccafoschi, F. & Mantovani, D. Design of a perfusion bioreactor specific to the regeneration of vascular tissues under mechanical stresses. Artif. Organs 29, 906-912 (2005).
101. Boccafoschi, F., Habermehl, J., Vesentini, S. & Mantovani, D. Biological performances of collagen-based scaffolds tor vascular tissue engineering. Biomaterials 26, 7410-7417 (2005).
102. Crombez, M. et al. Improving arterial prosthesis neo-endothelialization: Application of a proactive VEGF construct onto PTFE surfaces. Biomaterials 26, 7402-7409 (2005).
103. Rajan, N., Habermehl, J., Cote, M. F., Doillon, C. J. & Mantovani, D. Preparation of readytouse, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat. Protoc. 1, 2753-2758 (2006).
104. Boccafoschi, F., Rajan, N., Habermehl, J. & Mantovani, D. Preparation and characterization of a scaffold for vascular tissue engineering by direct-assembling of collagen and cells in a cylindrical geometry. Macromol. Biosci. 7, 719-726 (2007).
105. Couet, F., Rajan, N. & Mantovani, D. Macromolecular biomaterials for scaffold-based vascular tissue engineering. Macromol. Biosci. 7, 701-718 (2007).
106. Couet, F., Rajan, N., Vesentini, S. & Mantovani, D. Design of a collagen/silk mechano-compatible composite scaffold for the vascular tissue engineering: Focus on compliance. Key Eng. Mater. 334-335, 1169-1172 (2007).
107. Seliktar, D., Nerem, R. M. & Galis, Z. S. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng. 9, 657-666 (2003).
108. Schutte, S. C., Chen, Z. Z., Brockbank, K. G. M. & Nerem, R. M. Cyclic strain improves strength and function of a collagen-based tissue-engineered vascular media. Tissue Eng. Part A 16, 3149-3157 (2010).
109. Bulick, A. S. et al. Impact of endothelial cells and mechanical conditioning on smooth muscle cell extracellular matrix production and differentiation. Tissue Eng. Part A 15, 815-825 (2009).
110. Amadori, L., Rajan, N., Vesentini, S. & Mantovani, D. Atomic force and confocal microscopic studies of collagencellbased scaffolds for vascular tissue engineering. Adv. Mater. Res. 15-17, 83-88 (2007).
111. Couet, F. & Mantovani, D. Experimental validation of a new approach for the development of mechano-compatible composite scaffolds for vascular tissue engineering. J. Mater. Sci. Mater. Med. 19, 2551-2554 (2008).
112. Couet, F. & Mantovani, D. How to optimise the maturation conditions in a bioreactor? Toward an intelligent bioreactor for vascular tissue engineering [abstract]. Tissue Eng. Part A 14, 858 (2008).
113. Couet, F. & Mantovani, D. How to optimize maturation in a bioreactor for vascular tissue engineering: Focus on a decision algorithm for experimental planning. Ann. Biomed. Eng. 38, 2877-2884 (2010).
114. Couet, F. & Mantovani, D. A new bioreactor adapts to materials state and builds a growth model for vascular tissue engineering. Artif. Organs 36, 438-445 (2012).
115. Couet, F., Meghezi, S. & Mantovani, D. Fetal development, mechanobiology and optimal control processes can improve vascular tissue regeneration in bioreactors: An integrative review. Med. Eng. Phys. 34, 269-278 (2012).
116. Achilli, M., Lagueux, J. & Mantovani, D. On the effects of UVC and pH on the mechanical behavior, molecular conformation and cell viability of collagen-based scaffold for vascular tissue engineering. Macromol. Biosci. 10, 307-316 (2010).
117. Achilli, M., Meghezi, S., Lagueux, J. & Mantovani, D. Mechano-compatible collagen-based scaffolds for vascular tissue engineering: Low doses of UV affect the viscoelastic behaviour. Tissue Eng. Part A 14, 878-878 (2008).
118. Rajan, N. et al. Low doses of ultraviolet radiation stimulate cell activity in collagen-based scaffolds. Biotechnol. Prog. 24, 884-889 (2008).
119. Haisch, A. et al. Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med. Biol. Eng. Comput. 38, 686-689 (2000).
120. Swartz, D. D., Russell, J. A. & Andreadis, S. T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am. J. Physiol. Heart Circ. Physiol. 288, H1451-H1460 (2005).
121. Celebi, B., Cloutier, M., Balloni, R., Mantovani, D. & Bandiera, A. Human elastin-based recombinant biopolymers improve mesenchymal stem cell differentiation. Macromol. Biosci. 12, 1546-1554 (2012).
122. Tiwari, A., Salacinski, H., Seifalian, A. M. & Hamilton, G. New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc. Surg. 10, 191-197 (2002).
123. Kim, B. S., Nikolovski, J., Bonadio, J., Smiley, E. & Mooney, D. J. Engineered smooth muscle tissues: Regulating cell phenotype with the scaffold. Exp. Cell Res. 251, 318-328 (1999).
124. Williams, C. & Wick, T. M. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng. 10, 930-941 (2004).
125. Yow, K. H., Ingram, J., Korossis, S. A., Ingham, E. & Homer-Vanniasinkam, S. Tissue engineering of vascular conduits. Br. J. Surg. 93, 652-661 (2006).
126. Hubbell, J. A. Bioactive biomaterials. Curr. Opin. Biotechnol. 10, 123-129 (1999).
127. Ito, Y., Kajihara, M. & Imanishi, Y. Materials for enhancing cell adhesion by immobilization of cell-adhesive peptide. J. Biomed. Mater. Res. 25, 1325-1337 (1991).
128. Ye, Q. et al. Scaffold precoating with human autologous extracellular matrix for improved cell attachment in cardiovascular tissue engineering. ASAIO J. 46, 730-733 (2000).
129. Higgins, S. P., Solan, A. K. & Niklason, L. E. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J. Biomed. Mater. Res. A 67, 295-302 (2003).
130. Kurobe, H., Maxfield, M. W., Breuer, C. K. & Shinoka, T. Concise review: Tissue-engineered vascular grafts for cardiac surgery: Past, present, and future. Stem Cells Transl. Med. 1, 566-571 (2012).
131. Vogel, G. Tissue engineering: Mending the youngest hearts. Science 333, 1088-1089 (2011).
132. Dolgin, E. Taking tissue engineering to heart. Nat. Med. 17, 1032-1035 (2011).
133. Rosellini, E., Vozzi, G., Barbani, N., Giusti, P. & Cristallini, C. Three-dimensional microfabricated scaffolds with cardiac extracellular matrix-like architecture. Int. J. Artif. Organs 33, 885-894 (2010).
134. Quint, C. et al. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc. Natl Acad. Sci. USA 108, 9214-9219 (2011).
135. Keane, T. J., Londono, R. Turner, N. J. & Badylak, S. F. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 33, 1771-1781 (2012).
136. Mitchell, S., Koh, J., Probhakar, V. & Niklason, L. Decellularized tissue engineered constructs and tissues. US Patent 6,962,814 (2001).
137. Wolfinbarger, L. Jr, Lange, P., Linhurst Jones, A., Moore, E. & Nolf, B. Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced. US Patent 6,734,018 (2000).
138. Wolfinbarger, L. Jr, Lange, P., Linhurst Jones, A., Moore, E. & Nolf, B. Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced. US Patent 7,338,757 (2003).
139. Leyh, R. G. et al. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. J. Thorac. Cardiovasc. Surg. 126, 1000-1004 (2003).
140. Pasterkamp, G. et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150, 245-253 (2000).
141. Villalona, G. A. et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng. Part B Rev. 16, 341-350 (2010).
142. Cleary, M. A. et al. Vascular tissue engineering: The next generation. Trends Mol. Med. 18, 394-404 (2012).
143. Vilain, K. R. et al. Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: Results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Stroke 43, 2408-2416 (2012).
144. Shinoka, T. et al. Substrate for culture of cardiovascular tissue. US Patent 8,372,433 (2008).
145. McAllister, T. N., Garrido, S. & L'Heureux, N. Guided percutaneous bypass. US Patent 2012/0150092 (2010).
146. Smith, M. J. et al. Suture-reinforced electrospun polydioxanone-elastin small-diameter tubes for use in vascular tissue engineering: A feasibility study. Acta Biomater. 4, 58-66 (2008).